Travere Therapeutics, Inc. · NASDAQ:TVTX
The Vanguard Group reported a 5.65% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 5.65% stake in Travere Therapeutics, Inc., 5,014,020 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 5.65%
- Shares
- 5,014,020
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.65% | 5,014,020 |
Source
Related
- Travere Therapeutics, Inc.
- The Vanguard Group
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Jul 29, 2025
- Schedule 13G/A · The Vanguard Group · Jan 31, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026